Sanofi 14828

Enroll Now

Type of Study:

Adult Type 2

Title of Study:

Study comparing 4mg and 6 mg is non-inferior to placebo

Short Title:

EFC 14828

Study Length: 36 Weeks

Target Age/Sex: 18, Male and Female

Benefits:

Participants will receive at no cost: study medication and study related supplies, study related lab work and study related exams.

Link: ClinicalTrials.gov